Targacept (TRGT) Announces Positive Top-Line Results From Phase II Study of AZD3480 in Adult ADHD
Tweet Send to a Friend
Targacept, Inc. (NASDAQ: TRGT) announced preliminary results showing that AZD3480 (TC-1734) met the primary outcome measure in a Phase II ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
